Secondary Fracture Prevention

被引:6
作者
Adler, Robert A. [1 ,2 ,3 ]
机构
[1] McGuire Vet Affairs Med Ctr, Endocrinol & Metab Sect, Richmond, VA 23249 USA
[2] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Sch Med, Dept Epidemiol & Community Hlth, Richmond, VA 23298 USA
关键词
Osteoporosis; Fracture; Secondary prevention; Dual energy x-ray absorptiometry; Bisphosphonates;
D O I
10.1007/s11914-011-0090-z
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Osteoporosis causes no symptoms until there is a fracture. Although screening for osteoporosis is recommended for some populations, patients may present with a fragility fracture. Such patients are at high risk for subsequent fractures. Despite this high risk and the presence of generally safe and effective osteoporosis therapy, only a minority of low trauma fracture patients have evaluation and treatment of underlying osteoporosis. A brief summary of the evaluation and medical treatment of the post-fracture patient is provided. Several institutions, integrated health systems, and countries have instituted programs to identify, evaluate, and treat fragility fracture patients. Such programs have had variable success. This article describes some of the programs that work, their cost-effectiveness, and the applicability to the generally non-integrated US health care system. It is clear that better management of the post-fracture patient (and other high-risk patients) will lead to fewer fractures, decreased morbidity and mortality, and long-term cost savings.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 38 条
[1]
Adler RA, VHA MALE OSTEOPOROSI
[2]
Clinical utility of denosumab for treatment of bone loss in men and women [J].
Adler, Robert A. ;
Gill, Ranjodh S. .
CLINICAL INTERVENTIONS IN AGING, 2011, 6 :119-124
[3]
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture [J].
Andrade, SE ;
Majumdar, SR ;
Chan, KA ;
Buist, DSM ;
Go, AS ;
Goodman, M ;
Smith, DH ;
Platt, R ;
Gurwitz, JH .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) :2052-2057
[4]
[Anonymous], 2008, CLIN GUID PREV TREAT
[5]
Oral bisphosphonates are associated with reduced mortality after hip fracture [J].
Beaupre, L. A. ;
Morrish, D. W. ;
Hanley, D. A. ;
Maksymowych, W. P. ;
Bell, N. R. ;
Juby, A. G. ;
Majumdar, S. R. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) :983-991
[6]
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].
Black, Dennis M. ;
Delmas, Pierre D. ;
Eastell, Richard ;
Reid, Ian R. ;
Boonen, Steven ;
Cauley, Jane A. ;
Cosman, Felicia ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Mautalen, Carlos ;
Mesenbrink, Peter ;
Hu, Huilin ;
Caminis, John ;
Tong, Karen ;
Rosario-Jansen, Theresa ;
Krasnow, Joel ;
Hue, Trisha F. ;
Sellmeyer, Deborah ;
Eriksen, Erik Fink ;
Cummings, Steven R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822
[7]
Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[8]
It is time for everyone to own the bone [J].
Bunta, Andrew D. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 :S477-S482
[9]
Screening for Osteoporosis: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Bibbins-Domingo, Kirsten ;
Cantu, Adelita Gonzales ;
Curry, Susan ;
Dietrich, Allen J. ;
Flores, Glenn ;
Grossman, David ;
Isham, George ;
LeFevre, Michael L. ;
Leipzig, Rosanne M. ;
Melnikow, Joy ;
Melnyk, Bernadette ;
Nicholson, Wanda ;
Reyes, Carolina ;
Schwartz, J. Sanford ;
Wilt, Timothy .
ANNALS OF INTERNAL MEDICINE, 2011, 154 (05) :356-+
[10]
Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men [J].
Center, Jacqueline R. ;
Bliuc, Dana ;
Nguyen, Nguyen D. ;
Nguyen, Tuan V. ;
Eisman, John A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :1006-1014